Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (272 million pounds) spanning five years due to the United States' demand for confidential data.
This move was revealed after a government memo dated December was disclosed, revealing that President Emmerson Mnangagwa deemed the arrangement was "lopsided".
An official spokesman later explained that the United States was demanding access to biological samples for research and commercial purposes while refused to share the resulting advantages from future medical innovations.
"We will now turn to the challenging and unfortunate process of ending our health assistance in Zimbabwe," remarked American envoy to Zimbabwe Pamela Tremont publicly.
Her embassy noted the United States had provided more than $1.9bn for health programmes to Zimbabwe over the last two decades.
A physicians' group in Zimbabwe has appealed for more dialogue to find a agreement acceptable to all parties so the country's critical HIV treatment initiative can be sustained.
Broader Context
This rejection follows a similar situation in neighbouring Kenya, where a high court halted a related health funding agreement following concerns were raised about the safety of citizens' medical information.
Since resuming the presidency recently, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had administered assistance for the American government, but Trump stated its spending was "inefficient" and his administration was pursuing government-to-government agreements to enhance transparency and responsibility.
Based on reports, Sixteen nations in Africa have to date agreed to these new agreements, representing over $18.3bn of fresh investment.
Details of the Declined Deal
This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this collaboration could have provided extraordinary advantages for Zimbabwean communities, especially the 1.2 million men, women and children presently on HIV treatment via American-funded initiatives," Tremont added.
However, official spokesman Nick Mangwana said the proposed deal was "unequal".
"The proposal required Zimbabwe to share its genetic material and health information over an extended period, with no corresponding assurance of benefiting from any medical innovations – like new medicines or tests – that might be developed from that shared data," his statement read.
"In essence, our nation would supply the basic resources for medical research with no assurance that the resulting innovations would be available to our citizens if a new disease outbreak arise."
Sovereignty and International Frameworks
He also pointed out that the US's withdrawal from the global health body and its push of bilateral health agreements were disrupting structures previously set up via the international health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing system created to manage potential pandemics.
"This system is intended to guarantee that when a country provides its samples, the benefits – including vaccines and treatments – are distributed fairly, not monopolised solely by those with the funds to develop them."
Zimbabwe's reservations regarding the US deal "should not be misconstrued as hostility towards the US," he added.
"We are open to ongoing dialogue with our American counterparts on how subsequent collaboration could be structured in a manner that respects the sovereignty and dignity of both nations."
Medical Community Response
Medical experts expressed it understood the official position, but recommended that negotiations must proceed given that a large portion of the nation's HIV programmes depended on international support.
"Where specific concerns arise, such as those involving information security or implementation frameworks, these can often be addressed via detailed discussion and mutually agreed protections," it commented.
This impasse highlights the complex tensions between receiving much-needed foreign assistance and safeguarding a country's data in an increasingly interconnected world.